NCBS Home page
Accession List
Pathway List
Search
Authorized Users
Help
News archives

Enter a Search String

Special character and space not allowed in the query term. Search string should be at least 2 characters long.
Search in: Search for Match By

Molecule Parameter List for PIP3_PDK1

The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network.
The text color of a molecule is highlighted by color.
Statistics
PIP3_PDK1 participated asMoleculeSum total ofEnzymeSubstrate of an enzymeProduct of an enzymeSubstrate in ReactionProduct in Reaction
No. of occurrences1010001

Accession and Pathway Details
Accession NameAccession No.Accession TypePathway Link
AKT87Network
Shared_Object_AKT AKT_mod 
This is one of the sub-model of BDNF signaling cascade. PIP3 activies AKT, leading to accumulation of Rheb-GTP, a regulator of mTOR.

PIP3_PDK1 acting as a Molecule in  
AKT Network
NameAccession NamePathway NameInitial Conc.
(uM)
Volume
(fL)
Buffered
PIP3_PDK1AKT
Accession No. : 87
AKT_mod
Pathway No. : 1086
0999.97No

PIP3_PDK1 acting as an Enzyme in  
AKT Network
Enzyme Molecule /
Enzyme Activity
Accession NamePathway NameKm (uM)kcat (s^-1)RatioEnzyme TypeReagents
PIP3_PDK1 /
phospho_thr308
AKT
Accession No. : 87
AKT_mod
Pathway No. : 1086
0.399987104explicit E-S complexSubstrate
PIP3_AKT

Product
PIP3_AKT_thr308

PIP3_PDK1 acting as a Product in a reaction in  
AKT Network
Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider.
NameAccession NamePathway NameKfKbKdtauReagents
PIP3_bind_PDK1AKT
Accession No. : 87
AKT_mod
Pathway No. : 1086
0.7
(uM^-1 s^-1)
0.98
(s^-1)
Kd(bf) = 1.4(uM)-Substrate
PDK1
PIP3

Product
PIP3_PDK1



Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details.